Items Tagged ‘#Lymph2Cx test’

December 21, 2016

Mayo Clinic first in U.S. to offer lymphoma genomic diagnostic test for patients

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Article by Colette Gallagher, Public Affairs More than 20,000 people in the U.S. are diagnosed with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma each year. Mayo Clinic is the first site in the country to offer a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell […]

View full entry

Tags: #diffuse large B cell lymphoma, #Lymph2Cx test, #Mayo Clinic Molecular Diagnostic Arizona Laboratory, #non-Hodgkin's lymphoma, center for individualized medicine, lymphoma, mayo clinic, medical research, Precision Medicine


Contact Us · Privacy Policy